Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Finished Goods (2022 - 2025)

Historic Finished Goods for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to $11.6 million.

  • Arcutis Biotherapeutics' Finished Goods rose 4214.15% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 4214.15%. This contributed to the annual value of $9.6 million for FY2024, which is 25750.83% up from last year.
  • According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Finished Goods is $11.6 million, which was up 4214.15% from $7.9 million recorded in Q2 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Finished Goods peaked at $11.6 million during Q3 2025, and registered a low of $698000.0 during Q3 2022.
  • In the last 4 years, Arcutis Biotherapeutics' Finished Goods had a median value of $2.7 million in 2024 and averaged $5.0 million.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Finished Goods skyrocketed by 25750.83% in 2024, and later skyrocketed by 3523.04% in 2025.
  • Arcutis Biotherapeutics' Finished Goods (Quarter) stood at $1.5 million in 2022, then surged by 84.73% to $2.7 million in 2023, then soared by 257.51% to $9.6 million in 2024, then grew by 20.06% to $11.6 million in 2025.
  • Its Finished Goods was $11.6 million in Q3 2025, compared to $7.9 million in Q2 2025 and $8.3 million in Q1 2025.